 | • レポートコード：MRC2-11QY04274 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は色素沈着障害治療のグローバル市場について調査・分析したレポートです。種類別（薬物療法（外用薬、ハイドロキノン、L-アスコルビン酸、その他）、美容治療（ケミカルピーリング、レーザー治療、植皮、その他））市場規模、用途別（皮膚科クリニック、ドラッグストア・化粧品店、エステティッククリニック、Eコマース、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別色素沈着障害治療の競争状況、市場シェア ・世界の色素沈着障害治療市場：種類別市場規模 2015年-2020年（薬物療法（外用薬、ハイドロキノン、L-アスコルビン酸、その他）、美容治療（ケミカルピーリング、レーザー治療、植皮、その他）） ・世界の色素沈着障害治療市場：種類別市場規模予測 2021年-2026年（薬物療法（外用薬、ハイドロキノン、L-アスコルビン酸、その他）、美容治療（ケミカルピーリング、レーザー治療、植皮、その他）） ・世界の色素沈着障害治療市場：用途別市場規模 2015年-2020年（皮膚科クリニック、ドラッグストア・化粧品店、エステティッククリニック、Eコマース、その他） ・世界の色素沈着障害治療市場：用途別市場規模予測 2021年-2026年（皮膚科クリニック、ドラッグストア・化粧品店、エステティッククリニック、Eコマース、その他） ・北米の色素沈着障害治療市場分析：米国、カナダ ・ヨーロッパの色素沈着障害治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの色素沈着障害治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の色素沈着障害治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの色素沈着障害治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Bayer、Allergan、Episciences、La Roche-Posay、SkinCeuticals、Pierre Fabre、Alvogen、Obagi ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Skin pigmentation refers to a skin disorder that causes either lightening of skin or darkening of skin when compared to the existing skin color.
Pigmentation therapies can be classified as topical drugs, microdermabrasion, chemical peels, phototherapy, and laser therapy. These therapies are available in hospitals and aesthetic clinics & dermatology centers.
Market Analysis and Insights: Global Pigmentation Disorder Therapeutic Market
The global Pigmentation Disorder Therapeutic market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Pigmentation Disorder Therapeutic Scope and Market Size
Pigmentation Disorder Therapeutic market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pigmentation Disorder Therapeutic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Bayer
Allergan
Episciences
La Roche-Posay
SkinCeuticals
Pierre Fabre
Alvogen
Obagi
Market segment by Type, the product can be split into
Pharmacological Treatment (Topical Drugs, Hydroquinone, L-Ascorbic Acid, etc.)
Cosmetic Treatment (Chemical Peel, Laser Therapy, Skin Grafting, etc.)
Market segment by Application, split into
Dermatology Clinics
Drugstores and Cosmetic Stores
Aesthetic Clinics
E-commerce
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Pigmentation Disorder Therapeutic Revenue
1.4 Market by Type
1.4.1 Global Pigmentation Disorder Therapeutic Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Pharmacological Treatment (Topical Drugs, Hydroquinone, L-Ascorbic Acid, etc.)
1.4.3 Cosmetic Treatment (Chemical Peel, Laser Therapy, Skin Grafting, etc.)
1.5 Market by Application
1.5.1 Global Pigmentation Disorder Therapeutic Market Share by Application: 2020 VS 2026
1.5.2 Dermatology Clinics
1.5.3 Drugstores and Cosmetic Stores
1.5.4 Aesthetic Clinics
1.5.5 E-commerce
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Pigmentation Disorder Therapeutic Market Perspective (2015-2026)
2.2 Global Pigmentation Disorder Therapeutic Growth Trends by Regions
2.2.1 Pigmentation Disorder Therapeutic Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Pigmentation Disorder Therapeutic Historic Market Share by Regions (2015-2020)
2.2.3 Pigmentation Disorder Therapeutic Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Pigmentation Disorder Therapeutic Market Growth Strategy
2.3.6 Primary Interviews with Key Pigmentation Disorder Therapeutic Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Pigmentation Disorder Therapeutic Players by Market Size
3.1.1 Global Top Pigmentation Disorder Therapeutic Players by Revenue (2015-2020)
3.1.2 Global Pigmentation Disorder Therapeutic Revenue Market Share by Players (2015-2020)
3.1.3 Global Pigmentation Disorder Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Pigmentation Disorder Therapeutic Market Concentration Ratio
3.2.1 Global Pigmentation Disorder Therapeutic Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Pigmentation Disorder Therapeutic Revenue in 2019
3.3 Pigmentation Disorder Therapeutic Key Players Head office and Area Served
3.4 Key Players Pigmentation Disorder Therapeutic Product Solution and Service
3.5 Date of Enter into Pigmentation Disorder Therapeutic Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Pigmentation Disorder Therapeutic Historic Market Size by Type (2015-2020)
4.2 Global Pigmentation Disorder Therapeutic Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Pigmentation Disorder Therapeutic Market Size by Application (2015-2020)
5.2 Global Pigmentation Disorder Therapeutic Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Pigmentation Disorder Therapeutic Market Size (2015-2020)
6.2 Pigmentation Disorder Therapeutic Key Players in North America (2019-2020)
6.3 North America Pigmentation Disorder Therapeutic Market Size by Type (2015-2020)
6.4 North America Pigmentation Disorder Therapeutic Market Size by Application (2015-2020)
7 Europe
7.1 Europe Pigmentation Disorder Therapeutic Market Size (2015-2020)
7.2 Pigmentation Disorder Therapeutic Key Players in Europe (2019-2020)
7.3 Europe Pigmentation Disorder Therapeutic Market Size by Type (2015-2020)
7.4 Europe Pigmentation Disorder Therapeutic Market Size by Application (2015-2020)
8 China
8.1 China Pigmentation Disorder Therapeutic Market Size (2015-2020)
8.2 Pigmentation Disorder Therapeutic Key Players in China (2019-2020)
8.3 China Pigmentation Disorder Therapeutic Market Size by Type (2015-2020)
8.4 China Pigmentation Disorder Therapeutic Market Size by Application (2015-2020)
9 Japan
9.1 Japan Pigmentation Disorder Therapeutic Market Size (2015-2020)
9.2 Pigmentation Disorder Therapeutic Key Players in Japan (2019-2020)
9.3 Japan Pigmentation Disorder Therapeutic Market Size by Type (2015-2020)
9.4 Japan Pigmentation Disorder Therapeutic Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Pigmentation Disorder Therapeutic Market Size (2015-2020)
10.2 Pigmentation Disorder Therapeutic Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Pigmentation Disorder Therapeutic Market Size by Type (2015-2020)
10.4 Southeast Asia Pigmentation Disorder Therapeutic Market Size by Application (2015-2020)
11 India
11.1 India Pigmentation Disorder Therapeutic Market Size (2015-2020)
11.2 Pigmentation Disorder Therapeutic Key Players in India (2019-2020)
11.3 India Pigmentation Disorder Therapeutic Market Size by Type (2015-2020)
11.4 India Pigmentation Disorder Therapeutic Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Pigmentation Disorder Therapeutic Market Size (2015-2020)
12.2 Pigmentation Disorder Therapeutic Key Players in Central & South America (2019-2020)
12.3 Central & South America Pigmentation Disorder Therapeutic Market Size by Type (2015-2020)
12.4 Central & South America Pigmentation Disorder Therapeutic Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Bayer
13.1.1 Bayer Company Details
13.1.2 Bayer Business Overview
13.1.3 Bayer Pigmentation Disorder Therapeutic Introduction
13.1.4 Bayer Revenue in Pigmentation Disorder Therapeutic Business (2015-2020))
13.1.5 Bayer Recent Development
13.2 Allergan
13.2.1 Allergan Company Details
13.2.2 Allergan Business Overview
13.2.3 Allergan Pigmentation Disorder Therapeutic Introduction
13.2.4 Allergan Revenue in Pigmentation Disorder Therapeutic Business (2015-2020)
13.2.5 Allergan Recent Development
13.3 Episciences
13.3.1 Episciences Company Details
13.3.2 Episciences Business Overview
13.3.3 Episciences Pigmentation Disorder Therapeutic Introduction
13.3.4 Episciences Revenue in Pigmentation Disorder Therapeutic Business (2015-2020)
13.3.5 Episciences Recent Development
13.4 La Roche-Posay
13.4.1 La Roche-Posay Company Details
13.4.2 La Roche-Posay Business Overview
13.4.3 La Roche-Posay Pigmentation Disorder Therapeutic Introduction
13.4.4 La Roche-Posay Revenue in Pigmentation Disorder Therapeutic Business (2015-2020)
13.4.5 La Roche-Posay Recent Development
13.5 SkinCeuticals
13.5.1 SkinCeuticals Company Details
13.5.2 SkinCeuticals Business Overview
13.5.3 SkinCeuticals Pigmentation Disorder Therapeutic Introduction
13.5.4 SkinCeuticals Revenue in Pigmentation Disorder Therapeutic Business (2015-2020)
13.5.5 SkinCeuticals Recent Development
13.6 Pierre Fabre
13.6.1 Pierre Fabre Company Details
13.6.2 Pierre Fabre Business Overview
13.6.3 Pierre Fabre Pigmentation Disorder Therapeutic Introduction
13.6.4 Pierre Fabre Revenue in Pigmentation Disorder Therapeutic Business (2015-2020)
13.6.5 Pierre Fabre Recent Development
13.7 Alvogen
13.7.1 Alvogen Company Details
13.7.2 Alvogen Business Overview
13.7.3 Alvogen Pigmentation Disorder Therapeutic Introduction
13.7.4 Alvogen Revenue in Pigmentation Disorder Therapeutic Business (2015-2020)
13.7.5 Alvogen Recent Development
13.8 Obagi
13.8.1 Obagi Company Details
13.8.2 Obagi Business Overview
13.8.3 Obagi Pigmentation Disorder Therapeutic Introduction
13.8.4 Obagi Revenue in Pigmentation Disorder Therapeutic Business (2015-2020)
13.8.5 Obagi Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Pigmentation Disorder Therapeutic Key Market Segments
Table 2. Key Players Covered: Ranking by Pigmentation Disorder Therapeutic Revenue
Table 3. Ranking of Global Top Pigmentation Disorder Therapeutic Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Pigmentation Disorder Therapeutic Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Pharmacological Treatment (Topical Drugs, Hydroquinone, L-Ascorbic Acid, etc.)
Table 6. Key Players of Cosmetic Treatment (Chemical Peel, Laser Therapy, Skin Grafting, etc.)
Table 7. Global Pigmentation Disorder Therapeutic Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Pigmentation Disorder Therapeutic Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Pigmentation Disorder Therapeutic Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Pigmentation Disorder Therapeutic Market Share by Regions (2015-2020)
Table 11. Global Pigmentation Disorder Therapeutic Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Pigmentation Disorder Therapeutic Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Pigmentation Disorder Therapeutic Market Growth Strategy
Table 17. Main Points Interviewed from Key Pigmentation Disorder Therapeutic Players
Table 18. Global Pigmentation Disorder Therapeutic Revenue by Players (2015-2020) (Million US$)
Table 19. Global Pigmentation Disorder Therapeutic Market Share by Players (2015-2020)
Table 20. Global Top Pigmentation Disorder Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pigmentation Disorder Therapeutic as of 2019)
Table 21. Global Pigmentation Disorder Therapeutic by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Pigmentation Disorder Therapeutic Product Solution and Service
Table 24. Date of Enter into Pigmentation Disorder Therapeutic Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Pigmentation Disorder Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 27. Global Pigmentation Disorder Therapeutic Market Size Share by Type (2015-2020)
Table 28. Global Pigmentation Disorder Therapeutic Revenue Market Share by Type (2021-2026)
Table 29. Global Pigmentation Disorder Therapeutic Market Size Share by Application (2015-2020)
Table 30. Global Pigmentation Disorder Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 31. Global Pigmentation Disorder Therapeutic Market Size Share by Application (2021-2026)
Table 32. North America Key Players Pigmentation Disorder Therapeutic Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Pigmentation Disorder Therapeutic Market Share (2019-2020)
Table 34. North America Pigmentation Disorder Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 35. North America Pigmentation Disorder Therapeutic Market Share by Type (2015-2020)
Table 36. North America Pigmentation Disorder Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 37. North America Pigmentation Disorder Therapeutic Market Share by Application (2015-2020)
Table 38. Europe Key Players Pigmentation Disorder Therapeutic Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Pigmentation Disorder Therapeutic Market Share (2019-2020)
Table 40. Europe Pigmentation Disorder Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Pigmentation Disorder Therapeutic Market Share by Type (2015-2020)
Table 42. Europe Pigmentation Disorder Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Pigmentation Disorder Therapeutic Market Share by Application (2015-2020)
Table 44. China Key Players Pigmentation Disorder Therapeutic Revenue (2019-2020) (Million US$)
Table 45. China Key Players Pigmentation Disorder Therapeutic Market Share (2019-2020)
Table 46. China Pigmentation Disorder Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 47. China Pigmentation Disorder Therapeutic Market Share by Type (2015-2020)
Table 48. China Pigmentation Disorder Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 49. China Pigmentation Disorder Therapeutic Market Share by Application (2015-2020)
Table 50. Japan Key Players Pigmentation Disorder Therapeutic Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Pigmentation Disorder Therapeutic Market Share (2019-2020)
Table 52. Japan Pigmentation Disorder Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Pigmentation Disorder Therapeutic Market Share by Type (2015-2020)
Table 54. Japan Pigmentation Disorder Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Pigmentation Disorder Therapeutic Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Pigmentation Disorder Therapeutic Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Pigmentation Disorder Therapeutic Market Share (2019-2020)
Table 58. Southeast Asia Pigmentation Disorder Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Pigmentation Disorder Therapeutic Market Share by Type (2015-2020)
Table 60. Southeast Asia Pigmentation Disorder Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Pigmentation Disorder Therapeutic Market Share by Application (2015-2020)
Table 62. India Key Players Pigmentation Disorder Therapeutic Revenue (2019-2020) (Million US$)
Table 63. India Key Players Pigmentation Disorder Therapeutic Market Share (2019-2020)
Table 64. India Pigmentation Disorder Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 65. India Pigmentation Disorder Therapeutic Market Share by Type (2015-2020)
Table 66. India Pigmentation Disorder Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 67. India Pigmentation Disorder Therapeutic Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Pigmentation Disorder Therapeutic Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Pigmentation Disorder Therapeutic Market Share (2019-2020)
Table 70. Central & South America Pigmentation Disorder Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Pigmentation Disorder Therapeutic Market Share by Type (2015-2020)
Table 72. Central & South America Pigmentation Disorder Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Pigmentation Disorder Therapeutic Market Share by Application (2015-2020)
Table 74. Bayer Company Details
Table 75. Bayer Business Overview
Table 76. Bayer Product
Table 77. Bayer Revenue in Pigmentation Disorder Therapeutic Business (2015-2020) (Million US$)
Table 78. Bayer Recent Development
Table 79. Allergan Company Details
Table 80. Allergan Business Overview
Table 81. Allergan Product
Table 82. Allergan Revenue in Pigmentation Disorder Therapeutic Business (2015-2020) (Million US$)
Table 83. Allergan Recent Development
Table 84. Episciences Company Details
Table 85. Episciences Business Overview
Table 86. Episciences Product
Table 87. Episciences Revenue in Pigmentation Disorder Therapeutic Business (2015-2020) (Million US$)
Table 88. Episciences Recent Development
Table 89. La Roche-Posay Company Details
Table 90. La Roche-Posay Business Overview
Table 91. La Roche-Posay Product
Table 92. La Roche-Posay Revenue in Pigmentation Disorder Therapeutic Business (2015-2020) (Million US$)
Table 93. La Roche-Posay Recent Development
Table 94. SkinCeuticals Company Details
Table 95. SkinCeuticals Business Overview
Table 96. SkinCeuticals Product
Table 97. SkinCeuticals Revenue in Pigmentation Disorder Therapeutic Business (2015-2020) (Million US$)
Table 98. SkinCeuticals Recent Development
Table 99. Pierre Fabre Company Details
Table 100. Pierre Fabre Business Overview
Table 101. Pierre Fabre Product
Table 102. Pierre Fabre Revenue in Pigmentation Disorder Therapeutic Business (2015-2020) (Million US$)
Table 103. Pierre Fabre Recent Development
Table 104. Alvogen Company Details
Table 105. Alvogen Business Overview
Table 106. Alvogen Product
Table 107. Alvogen Revenue in Pigmentation Disorder Therapeutic Business (2015-2020) (Million US$)
Table 108. Alvogen Recent Development
Table 109. Obagi Business Overview
Table 110. Obagi Product
Table 111. Obagi Company Details
Table 112. Obagi Revenue in Pigmentation Disorder Therapeutic Business (2015-2020) (Million US$)
Table 113. Obagi Recent Development
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pigmentation Disorder Therapeutic Market Share by Type: 2020 VS 2026
Figure 2. Pharmacological Treatment (Topical Drugs, Hydroquinone, L-Ascorbic Acid, etc.) Features
Figure 3. Cosmetic Treatment (Chemical Peel, Laser Therapy, Skin Grafting, etc.) Features
Figure 4. Global Pigmentation Disorder Therapeutic Market Share by Application: 2020 VS 2026
Figure 5. Dermatology Clinics Case Studies
Figure 6. Drugstores and Cosmetic Stores Case Studies
Figure 7. Aesthetic Clinics Case Studies
Figure 8. E-commerce Case Studies
Figure 9. Others Case Studies
Figure 10. Pigmentation Disorder Therapeutic Report Years Considered
Figure 11. Global Pigmentation Disorder Therapeutic Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Pigmentation Disorder Therapeutic Market Share by Regions: 2020 VS 2026
Figure 13. Global Pigmentation Disorder Therapeutic Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Pigmentation Disorder Therapeutic Market Share by Players in 2019
Figure 16. Global Top Pigmentation Disorder Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pigmentation Disorder Therapeutic as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Pigmentation Disorder Therapeutic Revenue in 2019
Figure 18. North America Pigmentation Disorder Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Pigmentation Disorder Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Pigmentation Disorder Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Pigmentation Disorder Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Pigmentation Disorder Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Pigmentation Disorder Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Pigmentation Disorder Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
糖尿病性神経障害治療薬の世界市場（～2026年） A drug used to treat mental illness caused by diabetes Market Analysis and Insights: Global Diabetic Neurological Disorder Therapeutic Drug Market The global Diabetic Neurological Disorder Therapeutic Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CA…- 双極性障害治療の世界市場（～2026年） Bipolar disorder, also known as manic-depressive disorder, is a mental illness. It is a mental health problem that primarily affects mood. Symptoms of bipolar disorder are extreme irritability or agitation, a period of feeling empty, loss of interest in normal activities, sleep problems, etc. Accord…
- 脂質異常症治療の世界市場（～2026年） Lipid disorder means the people high blood levels of low-density lipoprotein (LDL) cholesterol, fats called triglycerides,. Several biopharma companies are focusing on developing effective solutions for treating lipid disorders. Companies involved in lipid disorder treatment market include Teva Phar…
- 季節性情動障害治療の世界市場（～2026年） Seasonal Affective Disorder is a type of depression that occurs during a certain time of the year. This disorder is related to changes in seasons, mostly occurs in winter but some people may have this disorder in summers as well. Seasonal affective disorder is most common in women, people between th…
- 甲状腺障害治療の世界市場（～2026年） Hormones released by thyroid gland play a crucial role in stimulating metabolism, growth, and calories processing. Globally, thyroid gland disorders such as hypothyroidism, hyperthyroidism, and thyroid nodules affect around 5% to 10% of the population. Hyperthyroidism and hypothyroidism affect major…